Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD)

$259,559R43FY2021CECDC

Addinex Technologies, Inc., New York NY

Investigators

Stanislav Roslyakovcontact

Linked publications, trials & patents

Trial NCT05790551

View original record on NIH RePORTER →

Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) · GrantIndex